• Je něco špatně v tomto záznamu ?

Determination of branched chain amino acids, methionine, phenylalanine, tyrosine and alpha-keto acids in plasma and dried blood samples using HPLC with fluorescence detection

R. Kand'ár, P. Žáková, J. Jirošová, M. Sladká

. 2009 ; 47 (5) : 565-572.

Jazyk angličtina Země Německo

Perzistentní odkaz   https://www.medvik.cz/link/bmc11019689

BACKGROUND: The determination of branched chain amino acids [BCAA; valine (Val), leucine (Leu), isoleucine (Ile)], alpha-keto acids derived from BCAA [BCKA; alpha-ketoisovaleric acid (KIV), alpha-ketoisocaproic acid (KIC), alpha-ketomethylvaleric acid (KMV)], methionine (Met), phenylalanine (Phe) and tyrosine (Tyr) is currently the most reliable approach for the diagnosis of maple syrup urine disease (MSUD), hypermethioninemia, phenylketonuria (PKU) and tyrosinemia. The aim of this study was to develop rapid and simple HPLC methods for measurement of BCAA, Met, Phe, Tyr and BCKA in plasma and dried blood samples. METHODS: Samples of peripheral venous blood with EDTA as anticoagulant were obtained from a group of healthy blood donors (n=70, 35 females, 27-41 years of age and 35 males, 28-43 years of age). Blood-spot samples from a group of newborns (n=80, 40 girls and 40 boys 3-5 days of age) were collected onto #903 Specimen Collection Paper and allowed to dry for at least 24 h before analysis. Prior to separation, the amino acids (AA) were derivatized with o-phthaldialdehyde (OPA) and BCKA with o-phenylenediamine (OPD). Reverse phase column chromatography (LiChroCart 125-4 Purospher RP-18e, 5 microm) was used for separation and fluorescence detection used to monitoring of effluent. For AA analysis, 25 mmol/L sodium hydrogenphosphate-methanol (90:10, v/v), pH 6.5+/-0.1 was used as mobile phase A and 100% methanol was used as mobile phase B. Measurement of BCKA used a mixture of methanol and deionized water (55:45, v/v) as mobile phase A and mobile phase B consisted of 100% methanol. RESULTS: Analytical performance of these methods was satisfactory for the determination of all AA and BCKA. The intra-assay and inter-assay coefficients of variation were below 10% and recovery ranged from 90%-110%. CONCLUSIONS: We have developed simple, rapid and selective HPLC methods with fluorescence detection for the determination of BCAA, Met, Phe, Tyr and BCKA in plasma and dried blood samples.

Citace poskytuje Crossref.org

000      
03692naa 2200421 a 4500
001      
bmc11019689
003      
CZ-PrNML
005      
20121030115107.0
008      
110714s2009 gw e eng||
009      
AR
024    __
$a 10.1515/cclm.2009.123 $2 doi
035    __
$a (PubMed)19290779
040    __
$a ABA008 $b cze $c ABA008 $d ABA008 $e AACR2
041    0_
$a eng
044    __
$a gw
100    1_
$a Kanďár, Roman $7 stk2007405945
245    10
$a Determination of branched chain amino acids, methionine, phenylalanine, tyrosine and alpha-keto acids in plasma and dried blood samples using HPLC with fluorescence detection / $c R. Kand'ár, P. Žáková, J. Jirošová, M. Sladká
314    __
$a Department of Biological and Biochemical Sciences, Faculty of Chemical Technology, University of Pardubice, Pardubice, Czech Republic. roman.kandar@upce.cz
520    9_
$a BACKGROUND: The determination of branched chain amino acids [BCAA; valine (Val), leucine (Leu), isoleucine (Ile)], alpha-keto acids derived from BCAA [BCKA; alpha-ketoisovaleric acid (KIV), alpha-ketoisocaproic acid (KIC), alpha-ketomethylvaleric acid (KMV)], methionine (Met), phenylalanine (Phe) and tyrosine (Tyr) is currently the most reliable approach for the diagnosis of maple syrup urine disease (MSUD), hypermethioninemia, phenylketonuria (PKU) and tyrosinemia. The aim of this study was to develop rapid and simple HPLC methods for measurement of BCAA, Met, Phe, Tyr and BCKA in plasma and dried blood samples. METHODS: Samples of peripheral venous blood with EDTA as anticoagulant were obtained from a group of healthy blood donors (n=70, 35 females, 27-41 years of age and 35 males, 28-43 years of age). Blood-spot samples from a group of newborns (n=80, 40 girls and 40 boys 3-5 days of age) were collected onto #903 Specimen Collection Paper and allowed to dry for at least 24 h before analysis. Prior to separation, the amino acids (AA) were derivatized with o-phthaldialdehyde (OPA) and BCKA with o-phenylenediamine (OPD). Reverse phase column chromatography (LiChroCart 125-4 Purospher RP-18e, 5 microm) was used for separation and fluorescence detection used to monitoring of effluent. For AA analysis, 25 mmol/L sodium hydrogenphosphate-methanol (90:10, v/v), pH 6.5+/-0.1 was used as mobile phase A and 100% methanol was used as mobile phase B. Measurement of BCKA used a mixture of methanol and deionized water (55:45, v/v) as mobile phase A and mobile phase B consisted of 100% methanol. RESULTS: Analytical performance of these methods was satisfactory for the determination of all AA and BCKA. The intra-assay and inter-assay coefficients of variation were below 10% and recovery ranged from 90%-110%. CONCLUSIONS: We have developed simple, rapid and selective HPLC methods with fluorescence detection for the determination of BCAA, Met, Phe, Tyr and BCKA in plasma and dried blood samples.
590    __
$a bohemika - dle Pubmed
650    _2
$a dospělí $7 D000328
650    _2
$a vrozené poruchy metabolismu aminokyselin $x krev $7 D000592
650    _2
$a větvené aminokyseliny $x krev $7 D000597
650    _2
$a krevní skvrny $7 D001801
650    _2
$a vysokoúčinná kapalinová chromatografie $x metody $7 D002851
650    _2
$a ženské pohlaví $7 D005260
650    _2
$a fluorescence $7 D005453
650    _2
$a lidé $7 D006801
650    _2
$a novorozenec $7 D007231
650    _2
$a ketokyseliny $x krev $7 D007651
650    _2
$a mužské pohlaví $7 D008297
650    _2
$a methionin $x krev $7 D008715
650    _2
$a fenylalanin $x krev $7 D010649
650    _2
$a referenční hodnoty $7 D012016
650    _2
$a tyrosin $x krev $7 D014443
700    1_
$a Žáková, Pavla, $d 1977- $7 xx0094681
700    1_
$a Jirosová, J
700    1#
$a Sladká, Milada. $7 xx0179980
773    0_
$t Clinical Chemistry & Laboratory Medicine $w MED00010886 $g Roč. 47, č. 5 (2009), s. 565-572 $x 1434-6621
910    __
$a ABA008 $b x $y 2
990    __
$a 20110715115406 $b ABA008
991    __
$a 20121030115110 $b ABA008
999    __
$a ok $b bmc $g 864517 $s 729568
BAS    __
$a 3
BMC    __
$a 2009 $x MED00010886 $b 47 $c 5 $d 565-572 $i 1434-6621 $m Clinical chemistry and laboratory medicine $n Clin Chem Lab Med
LZP    __
$a 2011-3B09/Bjvme

Najít záznam

Citační ukazatele

Pouze přihlášení uživatelé

Možnosti archivace

Nahrávání dat ...